{
    "organizations": [],
    "uuid": "7ceb6893eeeb0d75075317d850e9623958e03a86",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-shandong-xinhua-pharmaceutical-see/brief-shandong-xinhua-pharmaceutical-sees-rise-in-fy-profit-attributable-idUSFWN1PB0JI",
    "ord_in_thread": 0,
    "title": "BRIEF-Shandong Xinhua Pharmaceutical Sees Rise In FY Profit Attributable",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 16 (Reuters) - Shandong Xinhua Pharmaceutical Co Ltd :\n* EXPECTED TO RECORD RISE IN NET PROFIT ATTRIBUTABLE TO SHAREHOLDERS DURING 2017\n* SEES FY PROFIT ATTRIBUTABLE IN RANGE RMB 184 MILLION TO RMB 244 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-16T17:25:00.000+02:00",
    "crawled": "2018-01-17T20:03:02.048+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "shandong",
        "xinhua",
        "pharmaceutical",
        "co",
        "ltd",
        "expected",
        "record",
        "rise",
        "net",
        "profit",
        "attributable",
        "shareholder",
        "see",
        "fy",
        "profit",
        "attributable",
        "range",
        "rmb",
        "million",
        "rmb",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}